文献速递消化道肿瘤与早癌消化内镜

基线结肠镜检查低风险腺瘤患者进展期腺瘤、结直肠癌及结直肠癌死亡风险:系统综述与Meta分析

Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Gastroenterol · 2017-10-31

该系统综述与Meta分析纳入11项观察性研究(n=64,317),比较低风险腺瘤(LRA)患者与基线结肠镜正常者及一般人群的进展期腺瘤(AA)、结直肠癌(CRC)和CRC死亡风险。LRA患者AA风险较基线正常者小幅但显著升高(RR 1.55,95%CI 1.24-1.94;P=0.0001;I²=0%),但CRC风险及CRC死亡风险较一般人群显著降低(SIR 0.68、OR 0.4、SMR 0.75)。

要点

  • LRA患者进展期腺瘤风险较基线结肠镜正常者升高(RR 1.55,95%CI 1.24-1.94;P=0.0001;I²=0%)。
  • 5年累积AA发生率:无腺瘤组3.28%、LRA组4.9%、AA基线组17.13%。
  • LRA患者CRC风险及CRC死亡风险均低于一般人群(SIR 0.68、OR 0.4、SMR 0.75)。

核心结论

  • LRA患者进展期腺瘤风险较基线结肠镜正常者小幅但显著升高,而CRC风险及CRC相关死亡风险较一般人群显著降低。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed和Embase 2006年1月至2015年7月发表的观察性研究,纳入11项研究(n=64,317)。
  • 采用纽卡斯尔-渥太华量表(NOS)评价质量,GRADE框架评价证据强度。
  • 8项队列研究(n=10,139,随访3至10年)纳入AA的Meta分析。

主要发现

  • LRA患者AA风险较基线结肠镜正常者升高(RR 1.55,95%CI 1.24-1.94;P=0.0001;I²=0%)。
  • 5年累积AA发生率:无腺瘤组3.28%(95%CI 1.85-5.10%)、LRA组4.9%(95%CI 3.18-6.97%)、AA基线组17.13%(95%CI 11.97-23.0%)。
  • 两项无法合并的研究显示LRA患者CRC风险较一般人群降低:中位随访7.7年时标准化发病比0.68(95%CI 0.44-0.99),3-5年时OR 0.4(95%CI 0.2-0.6)。
  • 一项大型回顾性队列研究显示LRA患者CRC死亡风险较一般人群降低25%(SMR 0.75,95%CI 0.63-0.88;中位随访7.7年)。

关键数值与推荐

  • LRA患者AA风险较基线正常者升高(RR 1.55,95%CI 1.24-1.94;P=0.0001;I²=0%)。
  • 5年累积AA发生率:无腺瘤组3.28%(95%CI 1.85-5.10%)、LRA组4.9%(95%CI 3.18-6.97%)、AA基线组17.13%(95%CI 11.97-23.0%)。
  • LRA患者CRC风险较一般人群降低:SIR 0.68(95%CI 0.44-0.99;中位随访7.7年)、OR 0.4(95%CI 0.2-0.6;3-5年)。
  • LRA患者CRC死亡风险较一般人群降低25%(SMR 0.75,95%CI 0.63-0.88;中位随访7.7年)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We conducted a systematic review and meta-analysis of the risk of advanced adenomas (AAs), colorectal cancer (CRC), and/or CRC-related death among individuals with low-risk adenomas (LRAs). METHODS: We searched PubMed and Embase for studies published between January 2006 and July 2015. Quality and strength of the evidence were rated using the Newcastle-Ottawa Scale (NOS) and the GRADE framework, respectively. RESULTS: Eleven observational studies (n=64,317) were included. A meta-analysis of eight cohort studies (n=10,139, 3 to 10 years' follow-up) showed a small but statistically significant increase in the incidence of AAs in individuals with LRAs compared with those with a normal baseline colonoscopy (RR 1.55 (95% CI 1.24-1.94); P=0.0001; I2=0%). The pooled 5-year cumulative incidence of AA was 3.28% (95% CI: 1.85-5.10%), 4.9% (95% CI: 3.18-6.97%), and 17.13% (95% CI: 11.97-23.0%) for the no adenoma, LRA, and AA baseline groups, respectively. Two studies, which could not be pooled, showed a reduction in the risk of CRC in individuals with LRAs compared with the general population (standardized incidence ratio 0.68 (95% CI 0.44-0.99) at a median follow-up of 7.7 years and OR 0.4 (95% CI 0.2-0.6) at 3-5 years). One large retrospective cohort study found a 25% reduction in CRC mortality in individuals with LRAs compared with the general population (SMR 0.75 (95% CI 0.63-0.88) at a median follow-up of 7.7 years). CONCLUSIONS: We observed a small but significant increase in the risk of AAs in people with LRAs compared with those with a normal baseline colonoscopy, but compared with the general population, people with LRAs have significantly lower risks of CRC and of CRC-related mortality.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Dubé C, Yakubu M, McCurdy BR, et al. Risk of Advanced Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality in People With Low-Risk Adenomas at Baseline Colonoscopy: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017. PMID: 29087393. doi:10.1038/ajg.2017.360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。